Aclaris Therapeutics, Inc. (ACRS)
5.57
+0.07
(+1.27%)
USD |
NASDAQ |
Sep 21, 16:00
5.575
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics EPS Diluted (TTM) : -0.5852 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5852 |
| March 31, 2026 | -0.5604 |
| December 31, 2025 | -0.5297 |
| September 30, 2025 | -1.381 |
| June 30, 2025 | -1.368 |
| March 31, 2025 | -1.397 |
| December 31, 2024 | -1.512 |
| September 30, 2024 | -0.5198 |
| June 30, 2024 | -0.8267 |
| March 31, 2024 | -1.091 |
| December 31, 2023 | -1.274 |
| September 30, 2023 | -1.667 |
| June 30, 2023 | -1.553 |
| March 31, 2023 | -1.446 |
| December 31, 2022 | -1.331 |
| September 30, 2022 | -1.289 |
| June 30, 2022 | -1.335 |
| March 31, 2022 | -1.360 |
| December 31, 2021 | -1.626 |
| September 30, 2021 | -1.555 |
| June 30, 2021 | -1.459 |
| March 31, 2021 | -1.398 |
| Date | Value |
|---|---|
| December 31, 2020 | -1.201 |
| September 30, 2020 | -1.348 |
| June 30, 2020 | -2.436 |
| March 31, 2020 | -3.369 |
| December 31, 2019 | -3.906 |
| September 30, 2019 | -4.451 |
| June 30, 2019 | -4.170 |
| March 31, 2019 | -3.972 |
| December 31, 2018 | -4.041 |
| September 30, 2018 | -3.787 |
| June 30, 2018 | -3.36 |
| March 31, 2018 | -2.91 |
| December 31, 2017 | -2.41 |
| September 30, 2017 | -2.16 |
| June 30, 2017 | -2.03 |
| March 31, 2017 | -2.09 |
| December 31, 2016 | -2.26 |
| September 30, 2016 | -2.05 |
| June 30, 2016 | -6.66 |
| March 31, 2016 | -6.04 |
| December 31, 2015 | -5.39 |
| September 30, 2015 | -5.11 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 0.4187 |
| Nektar Therapeutics | -6.697 |
| Xeris Biopharma Holdings, Inc. | -0.1024 |
| Alumis, Inc. | -3.809 |
| ANI Pharmaceuticals, Inc. | 4.632 |